Introduction: The rVSVDG-ZEBOV-GP (Ervebo®) vaccine is both immunogenic and protective against Ebola. However, the vaccine can cause a broad range of transient adverse reactions, from headache to arthritis. Identifying baseline reactogenicity signatures can advance personalized vaccinology and increase our understanding of the molecular factors associated with such adverse events. Methods: In this study, we developed a machine learning approach to integrate prevaccination gene expression data with adverse events that occurred within 14 days post-vaccination. Results and Discussion: We analyzed the expression of 144 genes across 343 blood samples collected from participants of 4 phase I clinical trial cohorts: Switzerland, USA, Gabon, and Kenya. Our machine learning approach revealed 22 key genes associated with adverse events such as local reactions, fatigue, headache, myalgia, fever, chills, arthralgia, nausea, and arthritis, providing insights into potential biological mechanisms linked to vaccine reactogenicity.

Gonzalez Dias Carvalho, P.C., Dominguez Crespo Hirata, T., Mano Alves, L.Y., Moscardini, I.F., do Nascimento, A.P.B., Costa-Martins, A.G., et al. (2023). Baseline gene signatures of reactogenicity to Ebola vaccination: a machine learning approach across multiple cohorts. FRONTIERS IN IMMUNOLOGY, 14 [10.3389/fimmu.2023.1259197].

Baseline gene signatures of reactogenicity to Ebola vaccination: a machine learning approach across multiple cohorts

Sorgi S.;Santoro F.;Medaglini D.;
2023-01-01

Abstract

Introduction: The rVSVDG-ZEBOV-GP (Ervebo®) vaccine is both immunogenic and protective against Ebola. However, the vaccine can cause a broad range of transient adverse reactions, from headache to arthritis. Identifying baseline reactogenicity signatures can advance personalized vaccinology and increase our understanding of the molecular factors associated with such adverse events. Methods: In this study, we developed a machine learning approach to integrate prevaccination gene expression data with adverse events that occurred within 14 days post-vaccination. Results and Discussion: We analyzed the expression of 144 genes across 343 blood samples collected from participants of 4 phase I clinical trial cohorts: Switzerland, USA, Gabon, and Kenya. Our machine learning approach revealed 22 key genes associated with adverse events such as local reactions, fatigue, headache, myalgia, fever, chills, arthralgia, nausea, and arthritis, providing insights into potential biological mechanisms linked to vaccine reactogenicity.
2023
Gonzalez Dias Carvalho, P.C., Dominguez Crespo Hirata, T., Mano Alves, L.Y., Moscardini, I.F., do Nascimento, A.P.B., Costa-Martins, A.G., et al. (2023). Baseline gene signatures of reactogenicity to Ebola vaccination: a machine learning approach across multiple cohorts. FRONTIERS IN IMMUNOLOGY, 14 [10.3389/fimmu.2023.1259197].
File in questo prodotto:
File Dimensione Formato  
fimmu-14-1259197.pdf

accesso aperto

Descrizione: Articolo
Tipologia: PDF editoriale
Licenza: Creative commons
Dimensione 2.77 MB
Formato Adobe PDF
2.77 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11365/1252014